Amended Current Report Filing (8-k/a)
May 11 2020 - 08:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): May 7,
2020
America Great Health
(Exact name of registrant as specified in charter)
WYOMING
(State or other jurisdiction of incorporation)
0-27873
|
|
98-0178621
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
1609 W Valley Blvd., #338,
Alhambra, CA
|
|
91803
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant's telephone number, including area
code: (626) 576-1299
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
☐ Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
☐ Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
EXPLANATORY NOTE
This Amendment No. 1 to the Current Report on Form 8-K (this
“Amendment”) is being filed by America Great Health (the “Company”)
for the purpose of amending Item 4.01 Changes in
Registrant’s Certifying Accountant of that certain Current Report
on Form 8-K originally filed by the Company with the U.S.
Securities and Exchange Commission (“SEC”) on May 7th, 2020
(the “Original Form 8-K”) in connection with the changing of
auditors. As indicated in the Original Form 8-K, this Amendment is
being filed to also include Letter from MJF & Associates, as
specified in Item 9.01 Financial Statements and Exhibits.
Section 4. Matters Related to Accountants and
Financial Statements
Item 4.01. Changes in Registrant’s Certifying
Accountant
|
(a)
|
Resignation of Current Accountants
|
In April, 2019, America Great Health (the “Company”) was notified
of the resignation of its independent registered public accounting
firm, MJF & Associates, APC (“MJF”), effective that date. The
Company’s Board of Directors accepted the resignation of MJF upon
receipt of the notification and has commenced a search for a new
independent public accounting firm.
No report of MJF on the financial statements of the Company’s
fiscal years ended June 30, 2018 contained an adverse opinion or a
disclaimer of opinion or was qualified or modified as to
uncertainty, audit scope, or accounting principles, except that the
audit report on the consolidated financial statements of the
Company for the fiscal year ended June 30, 2018 contained an
uncertainty about the Company’s ability to continue as a going
concern.
MJF at the time of resignation had not been engaged to perform an
audit of the Company’s consolidated financial statements, or
released a report or opinion regarding the Company’s financial
statements, for the fiscal year ended June 30, 2019. During the
time of their engagement and up through their resignation on, there
were no disagreements with MJF on any matters of accounting
principles or practices, financial statement disclosure or auditing
scope and procedures which, if not resolved to the satisfaction of
MJF, would have caused MJF to make reference to the matter in their
report. There were no reportable events (as that term is described
in Item 304(a)(1)(v) of Regulation S-K) during the fiscal year
ended June 30, 2018, except as noted in the following
paragraph.
During the fiscal year ended June 30, 2018, there were the
following “reportable events” (as such term is defined in Item 304
of Regulation S-K). As disclosed in Part II, Item 9A of the
Company’s Form 10-K for the fiscal year ended June 30, 2018, the
Company’s management determined that the Company’s internal
controls over financial reporting were not effective as of the end
of such period due to the existence of material weaknesses related
to the following:
1. We identified material weaknesses in our ICFR primarily
attributable to (i) lack of segregation of incompatible duties; and
(ii) insufficient Board of Directors representation. These
weaknesses are due to our inadequate staffing during the period
covered by this report and our lack of working capital to hire
additional staff. Management has retained an outside, independent
financial consultant to record and review all financial data, as
well as prepare our financial reports, in order to mitigate this
weakness. Although management will periodically re-evaluate this
situation, at this point it considers that the risk associated with
such lack of segregation of duties and the potential benefits of
adding employees to segregate such duties are not cost justified.
We intend to hire additional accounting personnel to assist with
financial reporting as soon as our finances will allow.
These material weaknesses have not been remediated as of the date
of this Current Report on Form 8-K..
The Company has provided a copy of the foregoing disclosures to MJF
and requested that MJF furnish it with a letter addressed to the
Securities and Exchange Commission stating whether MJF agrees with
the above statements. A copy of MJF’s letter to the Securities and
Exchange Commission, dated May 8, 2020, is filed as Exhibit 16.1 to
this Form 8-K.
|
(b)
|
Engagement of New Accountants
|
On April 30, 2020, the Company engaged TAAD LLC (“TAAD”) as our
independent registered public accounting firm to audit the
Company’s consolidated financial statements for its fiscal year
ended June 30, 2019 and June 30, 2020.
During each of the Company’s two most recent fiscal years and
through the date of this report, (a) the Company has not engaged
TAAD as either the principal accountant to audit the Company’s
financial statements, or as an independent accountant to audit a
significant subsidiary of the Company and on whom the principal
accountant is expected to express reliance in its report; and (b)
the Company or someone on its behalf did not consult TAAD with
respect to (i) either: the application of accounting principles to
a specified transaction, either completed or proposed; or the type
of audit opinion that might be rendered on the Company’s financial
statements, or (ii) any other matter that was either the subject of
a disagreement or a reportable event as set forth in Items
304(a)(1)(iv) and (v) of Regulation S-K.
Item 9.01. Financial Statements and Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
AMERICA GREAT HEALTH
|
|
|
|
|
|
|
|
|
Dated: May 8, 2020
|
|
By:
|
/s/ Mike Q. Wang
|
|
|
|
President
|
|
|
|
|